Paper · 20161824
Development of a HTRF kinase assay for determination of Syk activity.
Harbert C and 3 others. Curr Chem Genomics, 2008. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Development of a HTRF kinase assay for determination of Syk activity. Papers, record 20161824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20161824
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,094,779 | Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. | Anal Biochem | 1999 | https://conductscience.org/library/papers/10094779 | PubMed |
| 2 | 10,689,303 | Tyrosine kinase SYK: essential functions for immunoreceptor signalling. | Immunol Today | 2000 | https://conductscience.org/library/papers/10689303 | PubMed |
| 3 | 12,669,029 | Issues and progress with protein kinase inhibitors for cancer treatment. | Nat Rev Drug Discov | 2003 | https://conductscience.org/library/papers/12669029 | PubMed |
| 4 | 16,356,459 | Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization. | Anal Biochem | 2006 | https://conductscience.org/library/papers/16356459 | PubMed |
| 5 | 15,212,616 | Targeting Syk as a treatment for allergic and autoimmune disorders. | Expert Opin Investig Drugs | 2004 | https://conductscience.org/library/papers/15212616 | PubMed |
| 6 | 17,662,659 | Syk kinase as a treatment target for therapy in autoimmune diseases. | Clin Immunol | 2007 | https://conductscience.org/library/papers/17662659 | PubMed |
| 7 | 7,957,236 | Signal-transduction therapy. A novel approach to disease management. | Eur J Biochem | 1994 | https://conductscience.org/library/papers/7957236 | PubMed |
| 8 | 15,507,431 | A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15507431 | PubMed |
| 9 | 12,471,243 | The protein kinase complement of the human genome. | Science | 2002 | https://conductscience.org/library/papers/12471243 | PubMed |
| 10 | 15,180,536 | The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy. | Curr Pharm Des | 2004 | https://conductscience.org/library/papers/15180536 | PubMed |
1 to 10 of 17
See all 17 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,717,771 | Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30717771 | PubMed |
| 26,552,670 | Method for Assaying the Lipid Kinase Phosphatidylinositol-5-phosphate 4-kinase α in Quantitative High-Throughput Screening (qHTS) Bioluminescent Format. | Methods Mol Biol | 2016 | https://conductscience.org/library/papers/26552670 | PubMed |
| 26,501,901 | Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase. | Methods Mol Biol | 2016 | https://conductscience.org/library/papers/26501901 | PubMed |
| 21,643,507 | Two High Throughput Screen Assays for Measurement of TNF-α in THP-1 Cells. | Curr Chem Genomics | 2011 | https://conductscience.org/library/papers/21643507 | PubMed |
| 20,161,833 | HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications. | Curr Chem Genomics | 2009 | https://conductscience.org/library/papers/20161833 | PubMed |
| 20,161,830 | Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format. | Curr Chem Genomics | 2008 | https://conductscience.org/library/papers/20161830 | PubMed |
| 20,161,828 | Cellular Ser/Thr-kinase assays using generic peptide substrates. | Curr Chem Genomics | 2008 | https://conductscience.org/library/papers/20161828 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SYK | 6,850 | PubTator's text mining | https://conductscience.org/library/genes/6850 | NCBI Gene |
| TXK | 7,294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20161824
GET https://conductscience.org/api/papers/v1/20161824/authors